Adialante
Adialante is a YC Spring 2026 (P26) company. Based in San Francisco, CA, USA. Team of 4.
About Adialante
Summary
Adialante builds a mobile MRI system that delivers diagnostic-grade cancer screening directly to outpatient clinics, replacing the need for hospital referrals, shielded rooms, and capital equipment purchases. The company redesigned MRI hardware, algorithms, and physics from the ground up so that any clinic, not just large hospital systems, can offer on-site imaging. Starting with prostate cancer, the service brings the full scanning workflow, including engineers and MRI technicians, to the clinic in a mobile unit.
Business model
Flat fee per completed scan.
Go-to-market
Clinics and medical practices are the buyers; they engage through a sales consultation to reserve a mobile MRI slot, with no capital commitment required to get started.
From the Y Combinator listing
Cancer screening without barriers
We know how to improve cancer outcomes by 8x-10x: you catch it early. MRI is the most robust and powerful cancer-detection tool in the world, yet systems cost millions to purchase, take months to install, and require high levels of technical skill to operate. We've redesigned MRI from the ground up with new physics, algorithms, and hardware, all to bring cancer screening to the entire world. Our mobile MRI is an imaging clinic on wheels. No equipment to buy, no infrastructure needed. For a flat per-scan fee, any medical site can offer MRI cancer screening. Starting with prostate cancer. Then everything else.
Facts
- Healthcare / Healthcare -> Diagnostics
- San Francisco, CA, USA
- 4
- Active
- Early
Founders (2)
- Parker Jenkins
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works